Novartis India (BOM:500672) Change In Receivables : ₹0 Mil (TTM As of Mar. 2024)

View and export this data going back to 1991. Start your Free Trial

What is Novartis India Change In Receivables?

Novartis India's change in receivables for the quarter that ended in Mar. 2024 was ₹0 Mil. It means Novartis India's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Novartis India's change in receivables for the fiscal year that ended in Mar. 2024 was ₹-53 Mil. It means Novartis India's Accounts Receivable increased by ₹53 Mil from Mar. 2023 to Mar. 2024 .

Novartis India's Accounts Receivable for the quarter that ended in Mar. 2024 was ₹415 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Novartis India's Days Sales Outstanding for the three months ended in Mar. 2024 was 46.62.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Novartis India's liquidation value for the three months ended in Mar. 2024 was ₹4,703 Mil.

Novartis India Change In Receivables Historical Data

The historical data trend for Novartis India's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis India Change In Receivables Chart

Novartis India Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

81.40

-9.20

-48.50

90.70

-53.40

Novartis India Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Novartis India Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Novartis India (BOM:500672) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Novartis India's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	414.7	/	811.7	*	91
=	46.62

2. In Ben Graham's calculation of liquidation value, Novartis India's accounts receivable are only considered to be worth 75% of book value:

Novartis India's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	5968.9	-	1801.1	+	0.75 * 414.7	+	0.5 * 448.6
=	4,703

Novartis India Change In Receivables Related Terms

Thank you for viewing the detailed overview of Novartis India's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis India (BOM:500672) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis India Ltd (BOM:500672) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

Inspire BKC, Part of 601 & 701, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051

Website

https://www.novartis.in

Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company single business segment namely Pharmaceuticals, Its Pharmaceutical business focuses on Bone and Pain, Calcium portfolio, Gynecology, and Neurosciences.

Novartis India (BOM:500672) Headlines

No Headlines